Volume No. :   4

Issue No. :  3

Year :  2012

ISSN Print :  0975-4407

ISSN Online :  2321-5836


Registration

Allready Registrered
Click to Login

Overview on Acquired immunodeficiency syndrome



Address:   R.T. Kakade1, S.D.Firke2, P.S. Bafna2, A.K. Tilva1
1NGSPMs College of Pharmacy, Anjaneri, Nashik, Maharashtra.
2H.R. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra
*Corresponding Author
DOI No: Not Available

ABSTRACT:
Acquired immunodeficiency syndrome (AIDS) causes an irreversible destruction of immune system. Currently, used drugs for treatment of HIV/AIDS act through inhibition of important viral enzymes such as reverse transcriptase, protease and/or integrase. Uncoating inhibitor has also been approved for treatment of AIDS with novel mode of action. However, it is now evident that the existing armoury of antiretroviral and even their triplet (cocktail) and/or quadruple (highly active antiretroviral therapy, HAART), will not lead to eradication of HIV infection. Therefore recently scientists have proposed different targets and treatment approaches towards the HIV/AIDS, which include entry inhibitors, transcription inhibitors, uncoating inhibitors, zinc finger inhibitors, gene therapy.
KEYWORDS:
AIDS, Life cycle, Recent targets
Cite:
RT Kakade, SD Firke, PS Bafna, AK Tilva. Overview on Acquired immunodeficiency syndrome . Research J. Pharmacology and Pharmacodynamics. 4(3): 2012;158-162.
[View HTML]      [View PDF]



Visitor's No. :   135486